Analysis of 10,131 hematological cancer patient samples showed the highest gene expression of PLA2G4A was in lymphoma, acute myeloid leukemia (AML), and multiple myeloma (MM) (Figure 3A). This evidence concerns the gene PLA2G4A and AL amyloidosis.